Stock PME PRO MEDICUS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pro Medicus Limited

Equities

PME

AU000000PME8

Advanced Medical Equipment & Technology

Market Closed - Australian S.E.
Other stock markets
 07:10:05 29/04/2024 BST 		5-day change 1st Jan Change
111.6 AUD +2.08% Intraday chart for Pro Medicus Limited +8.44% +16.51%
04-02 Pro Medicus Limited authorizes a Buyback Plan. CI
04-01 Pro Medicus Limited announces an Equity Buyback for 10,442,488 shares, representing 10% of its issued share capital. CI

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,620 2,750 6,119 4,406 6,855 11,659 - -
Enterprise Value (EV) 1 2,588 2,709 6,060 4,318 6,735 11,532 11,484 11,422
P/E ratio 138 x 120 x 199 x 99.4 x 113 x 147 x 112 x 88.6 x
Yield 0.42% 0.45% 0.26% 0.52% 0.46% 0.34% 0.44% 0.59%
Capitalization / Revenue 52.3 x 48.4 x 90.1 x 47.1 x 54.9 x 72.6 x 57.2 x 46.6 x
EV / Revenue 51.7 x 47.7 x 89.3 x 46.2 x 53.9 x 71.9 x 56.4 x 45.6 x
EV / EBITDA 81 x 72.2 x 121 x 61.9 x 73.5 x 98.1 x 75.6 x 59.7 x
EV / FCF 99.3 x 101 x 187 x 100 x 109 x 154 x 120 x 95.6 x
FCF Yield 1.01% 0.99% 0.54% 1% 0.92% 0.65% 0.84% 1.05%
Price to Book 53.2 x 45.7 x 74.9 x 43.3 x 49.4 x 63.7 x 48.1 x 36.7 x
Nbr of stocks (in thousands) 103,617 103,947 104,212 104,282 104,432 104,425 - -
Reference price 2 25.29 26.46 58.72 42.25 65.64 111.6 111.6 111.6
Announcement Date 21/08/19 19/08/20 17/08/21 17/08/22 14/08/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 50.1 56.82 67.88 93.46 124.9 160.5 203.7 250.5
EBITDA 1 31.96 37.53 49.89 69.75 91.62 117.5 151.9 191.5
EBIT 1 25.88 29.85 42.69 62.43 83.7 108.1 141.6 180.3
Operating Margin 51.65% 52.53% 62.89% 66.8% 67.01% 67.38% 69.54% 71.98%
Earnings before Tax (EBT) 1 26.12 30.02 42.87 63.08 86.13 110.8 145.5 186
Net income 1 19.12 23.08 30.85 44.44 60.65 79.22 103.4 131.2
Net margin 38.17% 40.61% 45.45% 47.55% 48.56% 49.36% 50.78% 52.39%
EPS 2 0.1830 0.2210 0.2950 0.4250 0.5800 0.7581 0.9946 1.260
Free Cash Flow 1 26.06 26.82 32.43 43.13 61.89 74.86 96 119.4
FCF margin 52.01% 47.19% 47.77% 46.15% 49.55% 46.65% 47.14% 47.68%
FCF Conversion (EBITDA) 81.53% 71.45% 65% 61.84% 67.55% 63.69% 63.19% 62.37%
FCF Conversion (Net income) 136.27% 116.21% 105.12% 97.05% 102.04% 94.51% 92.82% 91%
Dividend per Share 2 0.1050 0.1200 0.1500 0.2200 0.3000 0.3841 0.4895 0.6598
Announcement Date 21/08/19 19/08/20 17/08/21 17/08/22 14/08/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2 2026 S1
Net sales 1 29.29 27.53 31.59 36.3 44.33 49.13 56.89 68.01 74.11 83.66 96.45 109.7 121
EBITDA 1 18.48 19.05 21.98 27.91 33.27 36.48 41.48 50.14 51.18 61.73 - - -
EBIT 1 14.7 15.15 18.3 24.39 29.7 32.73 37.59 46.1 46.78 58.31 64.96 73.55 83.45
Operating Margin 50.19% 55.02% 57.94% 67.2% 67.01% 66.61% 66.09% 67.78% 63.12% 69.7% 67.35% 67.04% 68.95%
Earnings before Tax (EBT) - - - - - - - 48.03 - - - - -
Net income 1 12.05 11.02 13.54 17.31 20.68 23.77 27.19 33.46 36.25 41.3 - - -
Net margin 41.15% 40.04% 42.87% 47.69% 46.64% 48.37% 47.79% 49.2% 48.91% 49.36% - - -
EPS 2 0.1154 0.1056 0.1295 0.1655 0.1971 0.2279 0.2596 0.3204 0.3461 0.4145 0.4700 0.5100 0.5800
Dividend per Share 2 0.0600 - - 0.0800 0.1000 - - 0.1700 - 0.2000 - - -
Announcement Date 12/02/20 19/08/20 16/02/21 17/08/21 15/02/22 17/08/22 14/02/23 14/08/23 14/02/24 - - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 32.3 41.2 59.2 88.3 120 128 175 237
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 26.1 26.8 32.4 43.1 61.9 74.9 96 119
ROE (net income / shareholders' equity) 45.3% 42.2% 43.5% 48.5% 50.4% 49.3% 48.8% 47.7%
ROA (Net income/ Total Assets) 26.3% 25.7% 27.9% 31.4% 33.8% 35.2% 36.9% 37.1%
Assets 1 72.66 89.96 110.6 141.3 179.6 225.2 280.4 353.4
Book Value Per Share 2 0.4800 0.5800 0.7800 0.9800 1.330 1.750 2.320 3.040
Cash Flow per Share 2 0.2400 0.3000 0.3700 0.5900 0.6000 0.8000 0.9900 1.270
Capex 1 0.34 7.57 7.69 9.02 6.45 7.74 9.14 10.5
Capex / Sales 0.68% 13.32% 11.33% 9.65% 5.16% 4.82% 4.49% 4.17%
Announcement Date 21/08/19 19/08/20 17/08/21 17/08/22 14/08/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pro Medicus Limited

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
111.6 AUD
Average target price
95.57 AUD
Spread / Average Target
-14.40%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+16.51% 7.45B
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.71% 32.47B
SECTRA AB Stock Sectra AB
+23.49% 3.89B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-15.80% 3.17B
OMNICELL, INC. Stock Omnicell, Inc.
-27.19% 1.28B
LUNIT INC. Stock Lunit Inc.
-33.58% 1.09B
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-33.74% 902M
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+1.56% 893M
VERADIGM INC. Stock Veradigm Inc.
-23.93% 857M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-14.74% 693M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. PME Stock
  4. Financials Pro Medicus Limited